Chinese pharma company Jiangsu Hengrui to raise $1.27b in HK listing

FILE PHOTO: Bull statues are placed in font of screens showing the Hang Seng stock index and stock prices outside Exchange Square, in Hong Kong, China, August 18, 2023. REUTERS/Tyrone Siu/File photo

Scott Murdoch

21 May, 2025

Jiangsu Hengrui

Printed by Unregistered user on Fri, 05 Dec 2025 15:08:03 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Chinese pharma company Jiangsu Hengrui to raise $1.27b in HK listing

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

China's Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27b in Hong Kong IPO

China's CATL jumps in Hong Kong debut after world's biggest IPO so far this year

Read more from Greater China

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report

Baidu’s Kunlunxin eyes Hong Kong IPO after $283m fundraising

Chinese pharma company Jiangsu Hengrui to raise $1.27b in HK listing

Register Now to Unlock Premium Content

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

China's Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27b in Hong Kong IPO

China's CATL jumps in Hong Kong debut after world's biggest IPO so far this year

Read more from Greater China

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report

Baidu’s Kunlunxin eyes Hong Kong IPO after $283m fundraising